Results 81 to 90 of about 188,732 (189)

Medical treatment for thyroid-associated ophthalmopathy

open access: yes
The medical management of thyroid-associated ophthalmopathy has been, and remains a clinical challenge. Several drugs have been used. Systemic steroids seem to be beneficial in patients with active disease.
Perros P; Kendall-Taylor P
core   +5 more sources

Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer [PDF]

open access: yes, 2009
Background: Thyroid nodules are a common clinical problem, and differentiated thyroid cancer is becoming increasingly prevalent. Since the publication of the American Thyroid Association's guidelines for the management of these disorders was published in
Steward DL   +39 more
core   +1 more source

External radiotherapy of thyroid cancer [PDF]

open access: yes, 2001
Differentiated thyroid cancer comprises papillary, mixed papillary-follicular and follicular adenocarcinomas. They are mostly hormone-sensitive and respond to thyroid-stimulating hormone (TSH) suppression. The standard treatment is total thyroidectomy. I-
Pollinger, B., Dühmke, Eckhart
core   +1 more source

Unilateral Thyroid Associated Ophthalmopathy

open access: yes, 1998
At present, no laboratory test or clinical finding pathognomic for Thyroid Associated Ophthalmopathy (TAO) are currently recognized. The recognized clinical diagnostic criteria for TAO are: eyelid retraction or not, exophthalmos, optic nerve dysfunction,
Antonella Boschi, MD; S. Bianchi-Marzoli, MD; C. Kolanowski, MD; C. Sannace, MD; R. Brancato, MD; M. C. Manie, MD; C. Daumerie, MD
core  

Development and psychometric properties of the Thai Graves’ ophthalmopathy quality of life (GO-QOL) questionnaire

open access: yesJournal of Patient-Reported Outcomes, 2019
Purpose To develop and assess the psychometric properties of the Thai version of the Graves’ Ophthalmopathy Quality of Life (GO-QOL) questionnaire. Background Graves’ ophthalmopathy (GO) is a chronic condition that causes negative self-image and impaired
Mingkwan Lumyongsatien   +8 more
doaj   +1 more source

Does autoimmunity against thyroglobulin play a role in the pathogenesis of Graves’ ophthalmopathy: a review

open access: yesClinical Ophthalmology, 2015
Thayalini Shanmuganathan,1 Christian Girgis,2 Hooshang Lahooti,1 Bernard Champion,1 Jack R Wall1 1Department of Medicine, Nepean Clinical School, Nepean Hospital, The University of Sydney, Sydney, 2Department of Medicine, Westmead Millennium Institute ...
Shanmuganathan T   +4 more
doaj  

Relationship between magnetic resonance imaging signal intensity and volume of extraocular muscles in thyroid-associated ophthalmopathy with methylprednisolone pulse therapy

open access: yesClinical Ophthalmology, 2016
Tomoaki Higashiyama,1 Yasuhiro Nishida,2 Masahito Ohji1 1Department of Ophthalmology, 2Clinical Medical Education Center, Shiga University of Medical Science, Shiga, Japan Purpose: To characterize the relationship between inflammation and swelling of ...
Higashiyama T, Nishida Y, Ohji M
doaj  

Thyroid antibody-negative euthyroid Graves’ ophthalmopathy

open access: yes, 2016
TSH receptor antibodies (TRAbs) are the pathological hallmark of Graves’ disease, present in nearly all patients with the disease. Euthyroid Graves’ ophthalmopathy (EGO) is a well-recognized clinical entity, but its occurrence in patients with negative ...
Okosieme, Onyebuchi   +11 more
core   +1 more source

FOCUS-MUSE DWI outperforms MUSE and FOCUS DWIs in orbital imaging quality and staging thyroid-associated ophthalmopathy

open access: yesInsights into Imaging
Objectives To compare field-of-view optimized and constrained undistorted single-shot (FOCUS), multiplexed sensitivity-encoding (MUSE) and FOCUS-MUSE diffusion-weighted images (DWIs) in orbital imaging quality and staging performance for the patients ...
Lu Chen   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy